Crossref journal-article
Elsevier BV
Journal of Controlled Release (78)
Bibliography

Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004). Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. Journal of Controlled Release, 99(1), 83–101.

Authors 8
  1. D. Le Garrec (first)
  2. S. Gori (additional)
  3. L. Luo (additional)
  4. D. Lessard (additional)
  5. D.C. Smith (additional)
  6. M.-A. Yessine (additional)
  7. M. Ranger (additional)
  8. J.-C. Leroux (additional)
References 66 Referenced 203
  1. 10.1023/A:1010618632738 / Invest. New Drugs / Role of formulation vehicles in taxane pharmacology by Van Zuylen (2001)
  2. {'key': '10.1016/j.jconrel.2004.06.018_bib2', 'first-page': '1454', 'article-title': 'Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications', 'volume': '59', 'author': 'Sparreboom', 'year': '1999', 'journal-title': 'Cancer Res.'} / Cancer Res. / Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications by Sparreboom (1999)
  3. 10.1211/0022357021779104 / J. Pharm. Pharmacol. / Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel by Rodrigues (2002)
  4. {'key': '10.1016/j.jconrel.2004.06.018_bib4', 'first-page': '1862', 'article-title': 'Phase I trial in advanced malignancies with liposome-encapsulated paclitaxel (LEP) Q 3 weeks', 'volume': '21', 'author': 'Bowden', 'year': '2002', 'journal-title': 'Proc. Am. Soc. Clin. Oncol.'} / Proc. Am. Soc. Clin. Oncol. / Phase I trial in advanced malignancies with liposome-encapsulated paclitaxel (LEP) Q 3 weeks by Bowden (2002)
  5. {'key': '10.1016/j.jconrel.2004.06.018_bib5', 'first-page': '1038', 'article-title': 'Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel', 'volume': '8', 'author': 'Ibrahim', 'year': '2002', 'journal-title': 'Clin. Cancer Res.'} / Clin. Cancer Res. / Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel by Ibrahim (2002)
  6. 10.1016/S0168-3659(01)00299-1 / J. Control. Release / Structure and design of polymeric surfactant-based drug delivery systems by Torchilin (2001)
  7. 10.1016/S0169-409X(00)00124-1 / Adv. Drug Deliv. Rev. / Block copolymer micelles for drug delivery: design, characterization and biological significance by Kataoka (2001)
  8. 10.1517/14712598.1.4.583 / Expert Opin. Biol. Ther. / Block copolymeric biotransport carriers as versatile vehicles for drug delivery by Alakhov (2001)
  9. 10.2165/00137696-200402010-00002 / Am. J. Drug Deliv. / Micelles in anticancer drug delivery by Le Garrec (2004)
  10. 10.1016/j.addr.2003.07.013 / Adv. Drug Deliv. Rev. / Polymeric micelles to deliver photosensitizers for photodynamic therapy by Van Nostrum (2004)
  11. 10.1007/s002800050630 / Cancer Chemother. Pharmacol. / An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel by Zhang (1997)
  12. 10.1016/S0168-3659(01)00275-9 / J. Control. Release / In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy by Kim (2001)
  13. 10.1023/A:1022243709003 / Pharm. Res. / Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs by Krishnadas (2003)
  14. 10.1016/S0168-3659(03)00162-7 / J. Control. Release / Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ɛ-caprolactone) copolymer as a carrier for paclitaxel by Lee (2003)
  15. 10.1023/A:1011901921995 / Pharm. Res. / Development of novel chitosan derivatives as micellar carriers of taxol by Miwa (1998)
  16. 10.1002/(SICI)1099-1581(199911)10:11<647::AID-PAT918>3.0.CO;2-Y / Polym. Adv. Technol. / Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol by Kim (1999)
  17. 10.1016/j.addr.2003.12.004 / Adv. Drug Deliv. Rev. / Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs by Lukyanov (2004)
  18. 10.1016/j.jconrel.2004.03.009 / J. Control. Release / Antitumor characteristics of methoxypolyethylene glycol-poly(dl-lactic acid) nanoparticles containing campthotecin by Miura (2004)
  19. 10.1016/j.ijpharm.2003.12.012 / Int. J. Pharm. / All-trans-retinoic acid release from core shell type nanoparticles of poly(ε-caprolactone)/poly (ethylene glycol) diblock copolymer by Jeong (2004)
  20. 10.1016/0378-5173(95)04386-1 / Int. J. Pharm. / Development of amphiphilic diblock copolymers as micellar carriers of taxol by Zhang (1996)
  21. 10.1023/A:1011054930439 / Pharm. Res. / Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(d,l-lactide) by Benhamed (2001)
  22. 10.1002/jbm.820090505 / J. Biomed. Mater. Res. / Cell adhesion to polymeric materials: implications with respect to biocompatibility by Ratner (1975)
  23. 10.1002/jbm.820260707 / J. Biomed. Mater. Res. / Biocompatibility studies on plasma polymerized interface materials encompassing both hydrophobic and hydrophilic surfaces by Johnson (1992)
  24. 10.1081/PDT-100100550 / Pharm. Dev. Technol. / Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with carbamazepine. by Moneghini (2000)
  25. {'key': '10.1016/j.jconrel.2004.06.018_bib25', 'first-page': '281', 'article-title': 'Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy', 'volume': '8', 'author': 'Sharma', 'year': '1996', 'journal-title': 'Oncol. Res.'} / Oncol. Res. / Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy by Sharma (1996)
  26. 10.1016/0005-2736(94)90025-6 / Biochim. Biophys. Acta / Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo by Torchilin (1994)
  27. {'key': '10.1016/j.jconrel.2004.06.018_bib27', 'first-page': '6416', 'article-title': 'Antitumor activity of tumor necrosis factor-α conjugated with polyvinylpyrrolidone on solid tumors in mice', 'volume': '60', 'author': 'Kamada', 'year': '2000', 'journal-title': 'Cancer Res.'} / Cancer Res. / Antitumor activity of tumor necrosis factor-α conjugated with polyvinylpyrrolidone on solid tumors in mice by Kamada (2000)
  28. 10.1016/j.jconrel.2003.09.014 / J. Control. Release / Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism by D'souza (2003)
  29. {'key': '10.1016/j.jconrel.2004.06.018_bib29', 'first-page': '190', 'article-title': 'Use of lyoprotectants in the freeze-drying of a model protein, Ribonuclease A', 'volume': '37', 'author': 'Townsend', 'year': '1988', 'journal-title': 'J. Parenter. Sci. Technol.'} / J. Parenter. Sci. Technol. / Use of lyoprotectants in the freeze-drying of a model protein, Ribonuclease A by Townsend (1988)
  30. D. Le Garrec, M. Kabbaj, J.C. Leroux, Preparation of nanodispersion for pharmaceutical applications, US Patent 10,101,572, 2002.
  31. 10.1016/0378-4347(94)00117-0 / J. Chromatogr., B, Biomed. Appl. / Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma by Sharma (1994)
  32. 10.1097/00007691-199706000-00014 / Ther. Drug Monit. / A simple and reliable reverse-phase high-performance liquid chromatographic procedure for determination of paclitaxel (taxol) in human serum by Andreeva (1997)
  33. 10.1021/ma035910q / Macromolecules / Novel amphiphilic diblock copolymer of low molecular weight poly(N-vinylpyrrolidone)-block-(d,l-lactide): synthesis, characterization and micellization by Luo (2004)
  34. 10.1021/ma971111u / Macromolecules / Synthesis and solution properties of fluorescently labeled amphiphilic (N-alkylacrylamide) oligomers by Yamazaki (1998)
  35. 10.1023/B:PHAM.0000029284.40637.69 / Pharm. Res. / A novel one-step drug loading procedure for water-soluble amphiphilic nanocarriers by Fournier (2004)
  36. 10.1016/0022-1759(83)90303-4 / J. Immunol. Methods / Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay by Mosmann (1983)
  37. 10.1016/S0168-3659(99)00114-5 / J. Control. Release / The design and synthesis of polymers for eukaryotic membrane disruption by Murthy (1999)
  38. 10.1016/0378-4347(94)00456-F / J. Chromatogr., B / Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching by Song (1995)
  39. 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F / Stat. Med. / Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians by Carpenter (2000)
  40. 10.1126/science.1078192 / Science / Micellar nanocontainers distribute to defined cytoplasmic organelles by Savic (2003)
  41. 10.1016/S0939-6411(02)00119-4 / Eur. J. Pharm. Biopharm. / Enhanced cellular accumulation of P-glycoprotein substrate, rhodamine 123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers by Zastre (2002)
  42. 10.1002/macp.1985.021860406 / Makromol. Chem. / Micelle-forming block copolymers: pinocytosis by macrophages and interaction with model membranes by Pratten (1985)
  43. 10.1097/00001813-199801000-00001 / Anti-Cancer Drugs / Preclinical pharmacokinetics of paclitaxel and docetaxel by Sparreboom (1998)
  44. {'key': '10.1016/j.jconrel.2004.06.018_bib44', 'series-title': 'Taxol: Science and Applications', 'first-page': '209', 'article-title': 'Preclinical antitumor activity of taxanes', 'volume': 'vol. 8', 'author': 'Rose', 'year': '1995'} / Taxol: Science and Applications / Preclinical antitumor activity of taxanes by Rose (1995)
  45. 10.3109/02652049009021832 / J. Microencapsul / In vitro and in vivo antitumoral activity of free, and encapsulated taxol by Bartoli (1990)
  46. 10.1023/A:1025021603288 / Pharm. Res. / A high-throughput combinatorial approach for the discovery of a Cremophor EL-free paclitaxel formulation by Chen (2003)
  47. {'key': '10.1016/j.jconrel.2004.06.018_bib47', 'first-page': '31', 'article-title': 'A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs', 'volume': '41', 'author': 'Tarr', 'year': '1987', 'journal-title': 'J. Parenter. Sci. Technol.'} / J. Parenter. Sci. Technol. / A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs by Tarr (1987)
  48. 10.1023/A:1018943021705 / Pharm. Res. / A mixed micellar formulation suitable for the parenteral administration of taxol by Alkan-Onyuksel (1994)
  49. 10.1016/S0169-409X(02)00015-7 / Adv. Drug Deliv. Rev. / Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery by Lavasanifar (2002)
  50. 10.1016/S0169-409X(02)00016-9 / Adv. Drug Deliv. Rev. / Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations by Liggins (2002)
  51. 10.1016/S0927-7765(99)00058-2 / Colloids Surf., B / Nano-engineering block copolymer aggregates for drug delivery by Allen (1999)
  52. 10.1002/jps.10533 / J. Pharm. Sci. / Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine by Liu (2004)
  53. {'key': '10.1016/j.jconrel.2004.06.018_bib53', 'series-title': 'International Conference on Harmonization; Guidance on Impurities: Residual Solvents', 'first-page': '67377', 'author': 'Hubbarb', 'year': '1997'} / International Conference on Harmonization; Guidance on Impurities: Residual Solvents by Hubbarb (1997)
  54. 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8 / Prostate / Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors by Leung (2000)
  55. 10.1097/00001813-199708000-00008 / Anti-Cancer Drugs / Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel by Zhang (1997)
  56. 10.2165/00003088-200342070-00005 / Clin. Pharmacokinet. / Pharmacological effects of formulation vehicles. Implications for cancer chemotherapy by Ten Tije (2003)
  57. 10.1093/jnci/90.4.300 / J. Natl. Cancer Inst. / Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study by Szebeni (1998)
  58. 10.1016/S0959-8049(01)00171-X / Eur. J. Cancer / Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation by Gelderblom (2001)
  59. 10.1016/S0168-3659(01)00451-5 / J. Control. Release / Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge by Yamamoto (2001)
  60. {'key': '10.1016/j.jconrel.2004.06.018_bib60', 'first-page': 'W4202', 'article-title': 'Ionically fixed polymeric nanoparticles as a novel drug carrier', 'volume': '4', 'author': 'Lee', 'year': '2002', 'journal-title': 'AAPS PharmSci'} / AAPS PharmSci / Ionically fixed polymeric nanoparticles as a novel drug carrier by Lee (2002)
  61. {'key': '10.1016/j.jconrel.2004.06.018_bib61', 'first-page': '5877', 'article-title': 'Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model', 'volume': '53', 'author': 'Sharma', 'year': '1993', 'journal-title': 'Cancer Res.'} / Cancer Res. / Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model by Sharma (1993)
  62. 10.1021/la035012n / Langmuir / Complex coacervation core micelles. Colloidal stability and aggregation mechanism by Van Der Burgh (2004)
  63. 10.1021/bc034113u / Bioconjug. Chem. / Core-cross-linked polymeric micelles as paclitaxel carriers by Shuai (2004)
  64. 10.1016/j.jconrel.2004.02.003 / J. Control. Release / Folate receptor targeted biodegradable polymeric doxorubicin micelles by Yoo (2004)
  65. 10.1073/pnas.0931428100 / Proc. Natl. Acad. Sci. / Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs by Torchilin (2003)
  66. 10.1080/1061186031000138623 / J. Drug Target. / PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing by Gao (2003)
Dates
Type When
Created 21 years ago (Aug. 11, 2004, 6:34 a.m.)
Deposited 6 years, 6 months ago (Feb. 4, 2019, 1:55 p.m.)
Indexed 4 weeks ago (Aug. 6, 2025, 8:17 a.m.)
Issued 21 years ago (Sept. 1, 2004)
Published 21 years ago (Sept. 1, 2004)
Published Print 21 years ago (Sept. 1, 2004)
Funders 0

None

@article{Le_Garrec_2004, title={Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation}, volume={99}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/j.jconrel.2004.06.018}, DOI={10.1016/j.jconrel.2004.06.018}, number={1}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Le Garrec, D. and Gori, S. and Luo, L. and Lessard, D. and Smith, D.C. and Yessine, M.-A. and Ranger, M. and Leroux, J.-C.}, year={2004}, month=sep, pages={83–101} }